Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study

The aim of this pilot study was to determine Clara cell protein (CC16) concentration in bronchoalveolar lavages (BAL) fluid from full-term and preterm (<37 weeks’ gestational age) neonates requiring respiratory support, having symptoms of neonatal respiratory distress syndrome, and at risk of bro...

Full description

Saved in:
Bibliographic Details
Main Authors: José Guzmán-Bárcenas, Antonio Calderón-Moore, Héctor Baptista-González, Claudine Irles
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2017/8074678
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547180055887872
author José Guzmán-Bárcenas
Antonio Calderón-Moore
Héctor Baptista-González
Claudine Irles
author_facet José Guzmán-Bárcenas
Antonio Calderón-Moore
Héctor Baptista-González
Claudine Irles
author_sort José Guzmán-Bárcenas
collection DOAJ
description The aim of this pilot study was to determine Clara cell protein (CC16) concentration in bronchoalveolar lavages (BAL) fluid from full-term and preterm (<37 weeks’ gestational age) neonates requiring respiratory support, having symptoms of neonatal respiratory distress syndrome, and at risk of bronchopulmonary dysplasia (BPD). We hypothesized that CC16 may be predictive of BPD diagnosis regardless of gestational age. BAL fluid CC16 was measured by ELISA at birth and at day 7 of life. Both groups that developed BPD showed significantly decreased BAL fluid CC16 levels compared to those infants that did not develop the disease. CC16 positively correlated with diagnosis of BPD and negatively with the severity of the disease. These results suggest that BAL fluid CC16 levels may have a diagnostic value at day 7 for BPD in both term and preterm infants. This study demonstrates the potential utility of BAL fluid CC16 levels as a biomarker for BPD in term infants.
format Article
id doaj-art-cd3c280bea28410690b957992ac5b732
institution Kabale University
issn 1198-2241
1916-7245
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-cd3c280bea28410690b957992ac5b7322025-02-03T06:45:58ZengWileyCanadian Respiratory Journal1198-22411916-72452017-01-01201710.1155/2017/80746788074678Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot StudyJosé Guzmán-Bárcenas0Antonio Calderón-Moore1Héctor Baptista-González2Claudine Irles3Department of Perinatal Hematology, Instituto Nacional de Perinatología Isidro Espinoza de los Reyes, Montes Urales 800, 11000 Lomas de Virreyes, CDMX, MexicoNeonatal Intensive Care Unit, Hospital Infantil de México, Dr. Márquez No. 162, Cuauhtémoc, 06720 Doctores, CDMX, MexicoDepartment of Perinatal Hematology, Instituto Nacional de Perinatología Isidro Espinoza de los Reyes, Montes Urales 800, 11000 Lomas de Virreyes, CDMX, MexicoDepartment of Physiology and Cellular Development, Instituto Nacional de Perinatología Isidro Espinoza de los Reyes, Montes Urales 800, 11000 Lomas de Virreyes, CDMX, MexicoThe aim of this pilot study was to determine Clara cell protein (CC16) concentration in bronchoalveolar lavages (BAL) fluid from full-term and preterm (<37 weeks’ gestational age) neonates requiring respiratory support, having symptoms of neonatal respiratory distress syndrome, and at risk of bronchopulmonary dysplasia (BPD). We hypothesized that CC16 may be predictive of BPD diagnosis regardless of gestational age. BAL fluid CC16 was measured by ELISA at birth and at day 7 of life. Both groups that developed BPD showed significantly decreased BAL fluid CC16 levels compared to those infants that did not develop the disease. CC16 positively correlated with diagnosis of BPD and negatively with the severity of the disease. These results suggest that BAL fluid CC16 levels may have a diagnostic value at day 7 for BPD in both term and preterm infants. This study demonstrates the potential utility of BAL fluid CC16 levels as a biomarker for BPD in term infants.http://dx.doi.org/10.1155/2017/8074678
spellingShingle José Guzmán-Bárcenas
Antonio Calderón-Moore
Héctor Baptista-González
Claudine Irles
Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study
Canadian Respiratory Journal
title Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study
title_full Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study
title_fullStr Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study
title_full_unstemmed Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study
title_short Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study
title_sort clara cell protein expression in mechanically ventilated term and preterm infants with respiratory distress syndrome and at risk of bronchopulmonary dysplasia a pilot study
url http://dx.doi.org/10.1155/2017/8074678
work_keys_str_mv AT joseguzmanbarcenas claracellproteinexpressioninmechanicallyventilatedtermandpreterminfantswithrespiratorydistresssyndromeandatriskofbronchopulmonarydysplasiaapilotstudy
AT antoniocalderonmoore claracellproteinexpressioninmechanicallyventilatedtermandpreterminfantswithrespiratorydistresssyndromeandatriskofbronchopulmonarydysplasiaapilotstudy
AT hectorbaptistagonzalez claracellproteinexpressioninmechanicallyventilatedtermandpreterminfantswithrespiratorydistresssyndromeandatriskofbronchopulmonarydysplasiaapilotstudy
AT claudineirles claracellproteinexpressioninmechanicallyventilatedtermandpreterminfantswithrespiratorydistresssyndromeandatriskofbronchopulmonarydysplasiaapilotstudy